Vasospastic angina and microvascular angina are differentially influenced by PON1 A632G polymorphism in the Japanese

Circulation Journal

Volumn 69, Issue 12, 2005, Pages 1466-1471

  Mashiba, Junko ^a   Koike, George ^a   Kamiunten, Hitoshi ^a   Ikeda, Manami ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Coronary vasospasm; Oxidative stress; Polymorphism; PON1 (paraoxonase 1 gene); Smoking

Indexed keywords

ADULT; AGED; ALLELE; ANGINA PECTORIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY SPASM; DISEASE ASSOCIATION; ETHNOLOGY; FEMALE; GENDER; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; HEREDITY; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PARAOXONASE 1 GENE; PATHOGENESIS; SMOKING; VASOSPASM;

ACETYLCHOLINE; AGED; ANGINA PECTORIS, VARIANT; ARYLDIALKYLPHOSPHATASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CORONARY VASOSPASM; EPIDEMIOLOGY, MOLECULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MICROVASCULAR ANGINA; MIDDLE AGED; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 28544434658     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1466     Document Type: Article

References (46)

1. Cannon CP, Braunwald E. Unstable angina and non-ST elevation myocardial infarction. In: Zipes DP, Libby P, Bonow RO, Braunwald E, editors. Heart disease, 7th edn. Philadelphia: Elsevier Saunders; 2005; 1243 - 1279.
2. Beltrame JF, Sasayama S, Maseri A. Racial heterogeneity in coronary artery vasomotor reactivity: Differences between Japanese and Caucasian patients. J Am Coll Cardiol 1999; 33: 1442 - 1452.
3. Pristipino C, Beltrame JF, Finocchiaro ML, Hattori R, Fujita M, Mongiardo R, et al. Major racial differences in coronary constrictor response between japanese and caucasians with recent myocardial infarction. Circulation 2000; 101: 1102 - 1108.
4. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation 1993; 87: 76 - 79.
5. Kugiyama K, Yasue H, Ohgushi M, Motoyama T, Kawano H, Inobe Y, et al. Deficiency in nitric oxide bioactivity in epicardial coronary arteries of cigarette smokers. J Am Coll Cardiol 1996; 28: 1161 - 1167.
6. Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers: Smoking as a cause of oxidative damage. N Engl J Med 1995; 332: 1198 - 1203.
7. Wei EP, Kontos HA, Christman CW, DeWitt DS, Povlishock JT. Superoxide generation and reversal of acetylcholine-induced cerebral arteriolar dilation after acute hypertension. Circ Res 1985; 57: 781 - 787.
8. Miwa K, Miyagi Y, Igawa A, Nakagawa K, Inoue H. Vitamin E defi-ciency in variant angina. Circulation 1996; 94: 14 - 18.
9. Kugiyama K, Motoyama T, Hirashima O, Ohgushi M, Soejima H, Misumi K, et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 103 - 109.
10. Motoyama T, Kawano H, Kugiyama K, Hirashima O, Ohgushi M, Tsunoda R, et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32: 1672 - 1679.
11. Yasue H, Kugiyama K. Coronary artery spasm: Japanese view. Coron Artery Dis 1990; 1: 668 - 673.
12. Murase Y, Yamada Y, Hirashiki A, Ichihara S, Kanda H, Watarai M, et al. Genetic risk and gene-environment interaction in coronary artery spasm in Japanese men and women. Eur Heart J 2004; 25: 970 - 977.
13. Ito T, Yasue H, Yoshimura M, Nakamura S, Nakayama M, Shimasaki Y, et al. Paraoxonase gene Gln192Arg (Q192R) polymorphism is associated with coronary artery spasm. Hum Genet 2002; 110: 89 - 94.
14. Chilian WM, Kuo L, DeFily DV, Jones CJ, Davis MJ. Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions. Eur Heart J 1993; 14(Suppl I): 55 - 59.
15. Mohri M, Koyanagi M, Egashira K, Tagawa H, Ichiki T, Shimokawa H, et al. Angina pectoris caused by coronary microvascular spasm. Lancet 1998; 351: 1165 - 1169.
16. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilatation in patients with angina pectoris and normal coronary angiograms. N Engl J Med 1993; 328: 1659 - 1664.
17. Masumoto A, Mohri M, Takeshita A. Three-year follow-up of the Japanese patients with microvascular angina attributable to coronary microvascular spasm. Int J Cardiol 2001; 81: 151 - 156.
18. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990; 322: 213 - 217.
19. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. How soon after quitting smoking does risk of heart attack decline? J Clin Epidemiol 1991; 44: 1247 - 1253.
20. Inoue N, Kawashima S, Kanazawa K, Yamada S, Akita H, Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 1998; 97: 135 - 137.
21. Humbert R, Adler DA, Disteche CM, Hassett C, Omiecinski CJ, Furlong CE. The molecular basis of the human serum paraoxonase activity polymorphism. Nat Genet 1993; 3: 73 - 76.
22. Stafforini DM, Satoh K, Atkinson DL, Tjoelker LW, Eberhardt C, Yoshida H, et al. Platelet-activating factor acetylhydrolase deficiency: A missense mutation near the active site of an anti-inflammatory phospholipase. J Clin Invest 1996; 97: 2784 - 2791.
23. Okumura K, Yasue H, Matsuyama K, Ogawa H, Kugiyama K, Ishizaka H, et al. Diffuse disorder of coronary artery vasomotility in patients with coronary spastic angina: Hyperreactivity to the constrictor effects of acetylcholine and the dilator effects of nitroglycerin. J Am Coll Cardiol 1996; 27: 45 - 52.
24. Soejima H, Miyamoto S, Kojima S, Hokamaki J, Tanaka T, Kawano H, et al. Coronary spastic angina in patients with connective tissue disease. Circ J 2004; 68: 367 - 370.
25. Takagi S, Goto Y, Hirose E, Terashima M, Sakuragi S, Suzuki S, et al. Successful treatment of refractory vasospastic angina with corticosteroids: Coronary arterial hyperactivity caused by local inflammation? Circ J 2004; 68: 17 - 22.
26. Dinauer MC, Pierce EA, Bruns GA, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22-phox): Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 1990; 86: 1729 - 1737.
27. Ushio-Fukai M, Zafari AM, Fukui T, Ishizaka N, Griendling KK. p22phox is a critical component of the superoxide-generating NADH/NADPH oxidase system and regulates angiotensin IIinduced hypertrophy in vascular smooth muscle cells. J Biol Chem 1996; 271: 23317 - 23321.
28. Munzel T, Hink U, Heitzer T, Meinertz T. Role for NADPH/NADH oxidase in the modulation of vascular tone. Ann NY Acad Sci 1999; 874: 386 - 400.
29. Parkos CA, Dinauer MC, Walker LE, Allen RA, Jesaitis AJ, Orkin SH. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. Proc Natl Acad Sci USA 1988; 85: 3319 - 3323.
30. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 2000; 102: 1744 - 1747.
31. Mackness MI, Arrol S, Durrington PN. Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein. FEBS Lett 1991; 286: 152 - 154.
32. Anderson TJ, Meredith IT, Yeung AC, Frei B, Selwyn AP, Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488 - 493.
33. Mackness B, Mackness MI, Arrol S, Turkie W, Durrington PN. Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification. FEBS Lett 1998; 423: 57 -60.
34. Van Lenten BJ, Hama SY, de Beer FC, Stafforini DM, McIntyre TM, Prescott SM, et al. Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response: Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J Clin Invest 1995; 96: 2758 - 2767.
35. Watson AD, Navab M, Hama SY, Sevanian A, Prescott SM, Stafforini DM, et al. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest 1995; 95: 774 - 782.
36. Winkler K, Winkelmann BR, Scharnagl H, Hoffmann MM, Grawitz AB, Nauck M, et al. Platelet-activating factor acetylhydrolase activity indicates angiographic coronary artery disease independently of systemic inflammation and other risk factors: The Ludwigshafen Risk and Cardiovascular Health Study. Circulation 2005; 111: 980 - 987.
37. Rosenthal SJ, Ginsburg R, Lamb IH, Baim DS, Schroeder JS. Efficacy of diltiazem for control of symptoms of coronary arterial spasm. Am J Cardiol 1980; 46: 1027 - 1032.
38. Sutsch G, Oechslin E, Mayer I, Hess OM. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. Int J Cardiol 1995; 52: 135 - 143.
39. Zeiher AM, Drexler H, Wollschlager H, Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 1991; 84: 1984 - 1992.
40. Kaski JC, Rosano G, Gavrielides S, Chen L. Effects of angiotens-inconverting enzyme inhibition on exercise-induced angina and ST segment depression in patients with microvascular angina. J Am Coll Cardiol 1994; 23: 652 - 657.
41. Iriarte M, Caso R, Murga N, Boveda J, Saenz R, Lopez de Argumedo M, et al. Enalapril-induced regression of hypertensive left ventricular hypertrophy, regional ischemia, and microvascular angina. Am J Cardiol 1995; 75: 850 - 852.
42. Kayikcioglu M, Payzin S, Yavuzgil O, Kultursay H, Can LH, Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003; 24: 1999 - 2005.
43. Kaski JC, Aldama G, Cosin-Sales J. Cardiac syndrome X: Diagnosis, pathogenesis and management. Am J Cardiovasc Drugs 2004; 4: 179 - 194.
44. Hayward CS, Kalnins WV, Kelly RP. Acute effects of 17beta-estradiol on ventricular and vascular hemodynamics in postmenopausal women. Am J Physiol Heart Circ Physiol 2000; 279: H2277 - H2284.
45. Rosano GM, Peters NS, Lefroy D, Lindsay DC, Sarrel PM, Collins P, et al. 17-beta-Estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996; 28: 1500 - 1505.
46. Roque M, Heras M, Roig E, Masotti M, Rigol M, Betriu A, et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998; 31: 139 - 143.